Who pays, who gets paid, and why the same scan costs $406 or $14,681

Two economies, moving in opposite directions

The cleanest way to read imaging's money is to notice it runs on two clocks. The equipment economy — scanners, service contracts, the four-vendor oligopoly — is a healthy ~$50-billion market compounding at 4–6% a year on the back of an aging planet, and nothing in the reimbursement debate threatens that trajectory. The interpretation economy, the part that pays the people who read the images, has been shrinking in real terms for two decades: US physician payment is down about a third since 2001 by the AMA's reckoning, while hospital payments tracked inflation. A machine that grows more valuable every year, read by a workforce paid less every year, is the central tension of this topic and the engine behind the consolidation reshaping the field.

The split bill explains the sticker shock

Almost every confusing thing about an imaging bill dissolves once you separate the technical component from the professional one. The radiologist's interpretation — the professional component — is a small slice, on the order of $100 for an MRI read. The rest is technical: the machine, the room, the shielding, the staff, the overhead. Because overhead differs enormously between a hospital outpatient department and a freestanding centre, the same study on the same class of scanner is billed at roughly two to three times more in the hospital, even though the images and often the reading radiologist are identical. Site of service, not physician skill or machine quality, is the dominant price variable — which is why the single highest-leverage decision a US patient can make is where a non-urgent scan is performed.

The efficiency adjustment, and why radiologists object

The 2026 fee schedule crystallised the squeeze. CMS granted a nominal ~3% rise in the conversion factor, then applied a 2.5% "efficiency adjustment" to roughly nine thousand non-time-based codes — on the premise that physicians get faster at a task over time — plus per-code RVU cuts and bundling that, for specific studies, turned the headline raise into a double-digit reduction. A bundled CTA head-and-neck lost about a quarter of its professional payment; breast tomosynthesis was cut for a third consecutive year. The ACR's objection is substantive rather than reflexive: modern cross-sectional studies generate more images, more reconstructions and more mandatory reporting elements than they did a decade ago, so the assumption of rising per-exam efficiency runs backwards to the clinical reality documented across this site.

Transparency revealed the problem it couldn't fix

The price-transparency rules of the 2020s were sold as a way to let patients shop and thereby lower costs. On cost, the evidence is modest — one state database saw imaging costs fall about 3% over five years, and variation has narrowed only slightly since the rules took effect. What transparency did accomplish was evidentiary: it made the thirtyfold price gap for an identical brain MRI a matter of public record rather than industry folklore, with $406 and $14,681 both published under the same federal rule. That gap is not explained by anything about the scan. It is explained by who owns the building, which insurer negotiated the rate, and what the local market will bear — the same forces that, one layer up, are pushing independent practices into the hospitals whose facility fees create the gap in the first place.